Page last updated: 2024-11-03

ag 1879 and Carcinoma, Medullary

ag 1879 has been researched along with Carcinoma, Medullary in 2 studies

3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine: Fyn kinase inhibitor

Carcinoma, Medullary: A carcinoma composed mainly of epithelial elements with little or no stroma. Medullary carcinomas of the breast constitute 5%-7% of all mammary carcinomas; medullary carcinomas of the thyroid comprise 3%-10% of all thyroid malignancies. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1141; Segen, Dictionary of Modern Medicine, 1992)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carlomagno, F1
Guida, T1
Anaganti, S1
Vecchio, G1
Fusco, A1
Ryan, AJ1
Billaud, M1
Santoro, M1
Liu, Z1
Falola, J1
Zhu, X1
Gu, Y1
Kim, LT1
Sarosi, GA1
Anthony, T1
Nwariaku, FE1

Other Studies

2 other studies available for ag 1879 and Carcinoma, Medullary

ArticleYear
Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors.
    Oncogene, 2004, Aug-12, Volume: 23, Issue:36

    Topics: Carcinoma, Medullary; Catalytic Domain; Cell Line; Drug Resistance; Enzyme Inhibitors; Mitogens; Pip

2004
Antiproliferative effects of Src inhibition on medullary thyroid cancer.
    The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:7

    Topics: Apoptosis; Carcinoma, Medullary; Cell Division; Cell Line, Tumor; CSK Tyrosine-Protein Kinase; Enzym

2004